These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1374 related articles for article (PubMed ID: 9445407)

  • 1. Axonal transection in the lesions of multiple sclerosis.
    Trapp BD; Peterson J; Ransohoff RM; Rudick R; Mörk S; Bö L
    N Engl J Med; 1998 Jan; 338(5):278-85. PubMed ID: 9445407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
    Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H
    Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
    Narayanan S; Francis SJ; Sled JG; Santos AC; Antel S; Levesque I; Brass S; Lapierre Y; Sappey-Marinier D; Pike GB; Arnold DL
    Neuroimage; 2006 Jan; 29(2):637-42. PubMed ID: 16126413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis.
    Wolswijk G; Balesar R
    Brain; 2003 Jul; 126(Pt 7):1638-49. PubMed ID: 12805111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging correlates of axonal swelling in chronic multiple sclerosis brains.
    Fisher E; Chang A; Fox RJ; Tkach JA; Svarovsky T; Nakamura K; Rudick RA; Trapp BD
    Ann Neurol; 2007 Sep; 62(3):219-28. PubMed ID: 17427920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
    Chang A; Tourtellotte WW; Rudick R; Trapp BD
    N Engl J Med; 2002 Jan; 346(3):165-73. PubMed ID: 11796850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.
    Bjartmar C; Kidd G; Mörk S; Rudick R; Trapp BD
    Ann Neurol; 2000 Dec; 48(6):893-901. PubMed ID: 11117546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demyelination versus remyelination in progressive multiple sclerosis.
    Bramow S; Frischer JM; Lassmann H; Koch-Henriksen N; Lucchinetti CF; Sørensen PS; Laursen H
    Brain; 2010 Oct; 133(10):2983-98. PubMed ID: 20855416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis.
    Evangelou N; Esiri MM; Smith S; Palace J; Matthews PM
    Ann Neurol; 2000 Mar; 47(3):391-5. PubMed ID: 10716264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
    Seewann A; Vrenken H; van der Valk P; Blezer EL; Knol DL; Castelijns JA; Polman CH; Pouwels PJ; Barkhof F; Geurts JJ
    Arch Neurol; 2009 May; 66(5):601-9. PubMed ID: 19433660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical demyelination and diffuse white matter injury in multiple sclerosis.
    Kutzelnigg A; Lucchinetti CF; Stadelmann C; Brück W; Rauschka H; Bergmann M; Schmidbauer M; Parisi JE; Lassmann H
    Brain; 2005 Nov; 128(Pt 11):2705-12. PubMed ID: 16230320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
    Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis.
    Metz I; Lucchinetti CF; Openshaw H; Garcia-Merino A; Lassmann H; Freedman MS; Atkins HL; Azzarelli B; Kolar OJ; Brück W
    Brain; 2007 May; 130(Pt 5):1254-62. PubMed ID: 17293360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
    Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
    Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axonal loss in multiple sclerosis: causes and mechanisms.
    Criste G; Trapp B; Dutta R
    Handb Clin Neurol; 2014; 122():101-13. PubMed ID: 24507515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis.
    Geurts JJ; Wolswijk G; Bö L; van der Valk P; Polman CH; Troost D; Aronica E
    Brain; 2003 Aug; 126(Pt 8):1755-66. PubMed ID: 12805104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
    Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.
    Parry A; Clare S; Jenkinson M; Smith S; Palace J; Matthews PM
    J Neurol; 2002 Sep; 249(9):1279-86. PubMed ID: 12242554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced number and activity of mitochondria in multiple sclerosis lesions.
    Witte ME; Bø L; Rodenburg RJ; Belien JA; Musters R; Hazes T; Wintjes LT; Smeitink JA; Geurts JJ; De Vries HE; van der Valk P; van Horssen J
    J Pathol; 2009 Oct; 219(2):193-204. PubMed ID: 19591199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Axonal damage in multiple sclerosis].
    Arbizu-Urdiain T; Martínez-Yélamos A
    Rev Neurol; 2000 Jun 16-30; 30(12):1223-7. PubMed ID: 10935255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.